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Short reports
Different guises of plasmacytoma-from skin to
bone
Y L Kwong, W K Ng
Abstract
A case is reported of a patient with plas-
macytoma which assumed different
clinicopathological features over seven
years. The tumour first presented as a
subcutaneous mass which was
misdiagnosed as anaplastic carcinoma.
Complete response to radiotherapy
ensued but recurrence took the form of
an intracerebral tumour. Further com-
plete response to "palliative" cortico-
steroids was followed by osseous lesions
three years later, when the diagnosis of
plasmacytoma was confirmed. This
report illustrates the highly variable
clinicopathological presentations of plas-
macytoma, including the rare primary
cutaneous manifestation.
( Clin Pathol 1994;47:951-953)
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Plasmacytoma is a localised collection of neo-
plastic plasma cells. These can occur during
the course of multiple myelomatosis or as an
isolated lesion (solitary plasmacytoma). The
latter commonly presents as lesions in bones
or the upper respiratory tract.' Primary cuta-
neous plasmacytoma without associated mar-
row plasmacytosis is very rare with few
published cases.2A We describe an unusual
case of plasmacytoma, presenting as sequen-
tial isolated mass lesions in three different
sites over seven years.
Case report
A 61 year old man presented in 1988 with a
painless lump about 4 cm in diameter in the
scalp, which had started as a small subcuta-
neous nodule and progressively increased in
size over two years. An x ray picture of the
skull did not show an osteolytic lesion. A
computed axial tomogram showed a subcuta-
neous mass with some erosion on the skull
bone underneath. Fine needle aspiration of
the mass was carried out and anaplastic small
cell carcinoma was diagnosed. No other pri-
mary site was detected. He was treated with
palliative radiotherapy, which resulted in
complete disappearance of the mass. He pre-
sented again in 1990 with right-sided hemi-
paresis. A computed tomogram showed a
mass in the left cerebral hemisphere. There
was no associated bony lesion. In view of the
original diagnosis of anaplastic small cell car-
cinoma, the lesion was regarded as a sec-
ondary deposit and the patient was treated
palliatively with dexamethasone without his-
tological examination. However, complete
neurological recovery ensued. A computed
tomogram performed a year later showed no
detectable cerebral lesion. The patient
defaulted on follow up.
He presented again in 1993 with bilateral
knee pain which he had had for two weeks.
Physical examination showed localised ten-
derness. An x ray picture showed osteolytic
lesions affecting the right proximal tibia and
left distal femur. A 99technetium bone scan
showed increased uptake in these areas. The
biopsy specimen of the osteolytic lesion
showed plasmacytoma. Bone marrow aspirate
and a trephine biopsy specimen showed nor-
mal marrow with no increase in plasma cells.
Local radiotherapy was given to the osteolytic
lesions with good clinical response. He was
asymptomatic during the latest follow up four
months later.
Pathology
The haematological findings are summarised
in the table. Blood counts, serum globulin,
and immunoelectrophoresis had been normal
throughout the clinical course. However,
Haematological and immunologicalfindings
Haemoglobin White cell count Platelet Serum globulin Immuno
Time (gil) (x 109/l) (x 10911) (gil) IgG IqM IgA electrophoresis Immunofixation
1988 115 9 0 280 NA NA NA NA NA NA
1990 133 10-4 322 32 NA NA NA NA NA
1993 106 15-5 514 33 1644 160 300 Normal Monoclonal IgG k
Serum globulin (normal range 24-36 g/l); IgG (mg/dl, normal range 700-1850 mg/dl); IgA (mg/dl, normal range 90-450 mg/dl); IgM (mg/dl, normal range
50-300 mg/dl).
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Figure 1 Osseous lesion
showing montonous sheets
ofplasma cells. Nuclei
showing "cogwheel"
chromatin arrangement
can be seen (arrowheads)
(haematoxylin and eosin).
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Figure 2 Fine needle
aspiration of scalp lesion,
showing sheets of
malignant cells with
extensive autolysis. In
retrospect, some cells
(arrowheads) also possess
"cogwheel" chromatin
arrangement
(haematoxylin and eosin).
using the more sensitive immunofixation
technique, serum monoclonal IgG A was
found in the latest serum sample.
Histological examination of the osteolytic
tibial lesion showed a monotonous prolifera-
tion of polygonal malignant cells with occa-
sional interspersed capillaries. The malignant
cells showed a distinct cell border, abundant
pyroninophilic cytoplasm, an occasional
perinuclear Golgi zone, eosinophilic Russell's
bodies, and frequent mitosis averaging 1-5
per high power field. Nuclei were round
and eccentric, showing chromatin clumping
with a cogwheel appearance (fig 1). Immuno-
histochemical staining showed that the cells
were positive for leucocyte common antigen,
vimentin, and monotypic A light chain, and
negative for epithelial membrane antigen
(EMA). The overall features were those of a
plasmacytoma.
A retrospective review of the fine needle
aspirate of the scalp lesion showed malignant
cells arranged in small clusters. The tumour
cells were similar in morphology to those of
the latest biopsy specimen (fig 2).
Immunohistochemical staining showed that
the cells were positive for leucocyte common
antigen (LCA).
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Discussion
This case is unusual in that it presented as a
rare primary cutaneous plasmacytoma, which
later relapsed as intracerebral and osseous
lesions, without associated marrow plasmacy-
tosis. Although the intracerebral lesion was
not proved histologically, given the clinical
history and the very good response to dexa-
methasone, it is probably justified to make
that presumptive diagnosis.
This case also illustrates the pitfalls in the
diagnosis of plasmacytoma, particularly when
it occurs in an unusual site such as the skin
and in the absence of a previous history of
myelomatosis. Cytologically, the neoplastic
plasma cells can assume various forms, rang-
ing from anaplastic large cells or signet ring
cells, which may mimic metastatic carcinoma,
to tadpole-like cells with rosette formation,
resembling peripheral neuroepithelioma.5 The
clue to cytological diagnosis is the presence of
a cogwheel chromatin pattern and prominent
Golgi zone in at least some of the tumour
cells. In contrast, poorly differentiated carci-
noma and anaplastic carcinoma tend to show
more nuclear membrane irregularities, while
small cell carcinoma of lung usually has
inconspicuous nucleoli and scanty cytoplasm.
With the increasing use of fine needle aspira-
tion cytology for the diagnosis of solid
tumours, it is important to recognise these
features so as not to miss the diagnosis.
Histologically, confusion with poorly differen-
tiated carcinoma because of similar histologi-
cal appearances could occur, compounded by
the fact that on immunophenotyping, plasma-
cytoma might be negative for LCA, but posi-
tive for EMA6 and occasionally cytokeratin.78
Demonstration of monotypic expression of
immunoglobulin light chain will help to
establish the diagnosis.9 Because plasma cell
neoplasms frequently express EMA and B
cells tend to lose LCA when they reach the
plasma cell stage, an incorrect diagnosis of
carcinoma might be made if a plasma cell
tumour exhibited EMA in the absence of
LCA. As EMA is not very specific to epithe-
lial cells,10 it should not be used as the sole
marker of epithelial origin in tumour diagno-
sis. Immunohistochemical study should be
used as a supplement to morphological
diagnosis; all diagnostic conclusions require
the correlation of immunohistochemical find-
ings with morphology. This distinction is
important, because localised plasmacytoma is
usually very amenable to treatment and has a
much better prognosis than metastatic carci-
noma or multiple myeloma," 12 as shown in
this case. Finally, all isolated plasmacytomas
should have long term follow up, because
recurrence may occur in distant sites or as
myelomatosis.
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